672
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Inhibition of hyaluronan synthesis in rats reduces renal ability to excrete fluid and electrolytes during acute hydration

, &
Pages 217-221 | Received 18 Jun 2013, Accepted 06 Aug 2013, Published online: 09 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sara Stridh, Fredrik Palm, Tomoko Takahashi, Mayumi Ikegami-Kawai & Peter Hansell. (2015) Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan. Upsala Journal of Medical Sciences 120:4, pages 233-240.
Read now

Articles from other publishers (6)

Baris Afsar & Rengin Elsurer Afsar. (2023) The role of glycosaminoglycans in blood pressure regulation. Microcirculation 30:8.
Crossref
Loay Salman, Laisel Martinez, Geovani Faddoul, Christina Manning, Karim Ali, Maya Salman & Roberto Vazquez-Padron. (2023) Hyaluronan Inhibition as a Therapeutic Target for Diabetic Kidney Disease: What Is Next?. Kidney360 4:6, pages e851-e860.
Crossref
B. Madhoolika, N.V. Anil Kumar & S. Balaji. (2017) In vitro analysis of 4-methylumbelliferone as a sole carbon source for Lactobacillus helveticus 2126 . Letters in Applied Microbiology 65:3, pages 249-255.
Crossref
Giancarlo Ghiselli. (2017) Drug-Mediated Regulation of Glycosaminoglycan Biosynthesis. Medicinal Research Reviews 37:5, pages 1051-1094.
Crossref
P. Hansell & F. Palm. (2015) A role for the extracellular matrix component hyaluronan in kidney dysfunction during ACE-inhibitor fetopathy. Acta Physiologica 213:4, pages 795-804.
Crossref
Nadine Nagy, Hedwich F. Kuipers, Adam R. Frymoyer, Heather D. Ishak, Jennifer B. Bollyky, Thomas N. Wight & Paul L. Bollyky. (2015) 4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer. Frontiers in Immunology 6.
Crossref